The spine journal : official journal of the North American Spine Society · 2026
Association between symptom duration and lesion severity at diagnosis in symptomatic adolescents with lumbar spondylolysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hiranaka Yoshiaki, Miyazaki Shingo, Kuroshima Kohei, Kitano Takahiro, Ryu Masao, Inoue Shinichi, Yurube Takashi, Tadokoro Ko
Аннотация
BACKGROUND CONTEXT: Lumbar spondylolysis (LS) is a fatigue-related fracture commonly seen in adolescents. Progressive-stage lesions at diagnosis have been associated with poorer prognosis, including lower bone union rates and a longer time to return to sport.
PURPOSE: To clarify the association between symptom duration, lesion stage at diagnosis, and bilateral involvement in symptomatic adolescents with LS, and to determine the optimal symptom duration cutoff for predicting the presence of a progressive-stage lesion at diagnosis.
STUDY DESIGN: Retrospective cross-sectional study.
PATIENT SAMPLE: A total of 652 symptomatic adolescent patients with LS managed conservatively using a uniform treatment protocol at one hospital and 4 affiliated clinics between 2015 and 2023.
OUTCOME MEASURES: Outcome measures included lesion stage based on computed tomography findings, lesion laterality (unilateral vs bilateral).
METHODS: Symptom duration was defined as the interval from onset of low back pain to magnetic resonance imaging-confirmed diagnosis of fresh LS. Patients were classified into 3 stages (very early, early, and progressive) based on computed tomography findings. Receiver operating characteristic curve analysis was performed to determine the optimal symptom duration cutoff for predicting the presence of a progressive-stage lesion at diagnosis.
RESULTS: Median symptom duration was 1.1 weeks for the very early stage, 2.1 weeks for the early stage, and 5.7 weeks for the progressive stage. Patients with progressive-stage LS had significantly longer symptom duration than those with very early or early-stage lesions (both p<.001). Symptom duration was also significantly longer in patients with bilateral LS than in those with unilateral LS (3.9 vs 2.0 weeks, p<.001). Receiver operating characteristic analysis identified a symptom duration cutoff of 3.0 weeks for patients whose main lesion was classified as progressive (area under the curve=0.775, 95% confidence interval: 0.729-0.821).
CONCLUSIONS: Longer symptom duration was associated with a more advanced lesion stage at diagnosis and bilateral involvement in adolescent LS. Early diagnostic interventions within 3-4 weeks of symptom onset may be critical for preventing stage progression and optimizing clinical outcomes.
PURPOSE: To clarify the association between symptom duration, lesion stage at diagnosis, and bilateral involvement in symptomatic adolescents with LS, and to determine the optimal symptom duration cutoff for predicting the presence of a progressive-stage lesion at diagnosis.
STUDY DESIGN: Retrospective cross-sectional study.
PATIENT SAMPLE: A total of 652 symptomatic adolescent patients with LS managed conservatively using a uniform treatment protocol at one hospital and 4 affiliated clinics between 2015 and 2023.
OUTCOME MEASURES: Outcome measures included lesion stage based on computed tomography findings, lesion laterality (unilateral vs bilateral).
METHODS: Symptom duration was defined as the interval from onset of low back pain to magnetic resonance imaging-confirmed diagnosis of fresh LS. Patients were classified into 3 stages (very early, early, and progressive) based on computed tomography findings. Receiver operating characteristic curve analysis was performed to determine the optimal symptom duration cutoff for predicting the presence of a progressive-stage lesion at diagnosis.
RESULTS: Median symptom duration was 1.1 weeks for the very early stage, 2.1 weeks for the early stage, and 5.7 weeks for the progressive stage. Patients with progressive-stage LS had significantly longer symptom duration than those with very early or early-stage lesions (both p<.001). Symptom duration was also significantly longer in patients with bilateral LS than in those with unilateral LS (3.9 vs 2.0 weeks, p<.001). Receiver operating characteristic analysis identified a symptom duration cutoff of 3.0 weeks for patients whose main lesion was classified as progressive (area under the curve=0.775, 95% confidence interval: 0.729-0.821).
CONCLUSIONS: Longer symptom duration was associated with a more advanced lesion stage at diagnosis and bilateral involvement in adolescent LS. Early diagnostic interventions within 3-4 weeks of symptom onset may be critical for preventing stage progression and optimizing clinical outcomes.